The predictability of the dose-response relationships for oral semaglutide support ongoing trials that include higher dose levels of oral semaglutide in people with T2D and obesity, to maximize efficacy by achieving levels of circulating semaglutide with oral dosing that more approximates levels achieved with higher dose of s.c
Your diabetes doctor considers your complete health picture, including eye disease status, when selecting the best medication, and slower titration of any drug can reduce ocular risks
Large observational cohorts, cardiovascular outcome trials, and pharmacovigilance analyses have not confirmed a clear increase in medullary thyroid carcinoma among treated patients
Dual Action: By targeting both GLP-1 and GIP receptors, tirzepatide may enhance metabolic responses and further improve weight loss outcomes
Diabetologia 2013;56(8):17161725
Strongly suggested to hold in mouth for 10 minutes if possible Might be easiest to utilize while showering